Melbourne researchers have made a world first breakthrough into creating blood stem cells that closely resemble those in the human body. And the discovery could soon lead to personalized treatments for children with leukemia and bone marrow failure disorders.
The research, led by Murdoch Children’s Research Institute (MCRI) and published in Nature Biotechnology, has overcome a major hurdle for producing human blood stem cells, which can create red cells, white blood cells and platelets, that closely match those in the human embryo.
MCRI Associate Professor Elizabeth Ng said the team had made a significant discovery in human blood stem cell development, paving the way for these lab-grown cells to be used in blood stem cell and bone marrow transplants.
The ability to take any cell from a patient, reprogram it into a stem cell and then turn these into specifically matched blood cells for transplantation will have a massive impact on these vulnerable patients’ lives.”
Elizabeth Ng, Associate Professor, MCRI
“Prior to this study, developing human blood stem cells in the lab that were capable of being transplanted into an animal model of bone marrow failure to make healthy blood cells had not been achievable. We have developed a workflow that has created transplantable blood stem cells that closely mirror those in the human embryo.
“Importantly, these human cells can be created at the scale and purity required for clinical use.”
In the study, immune deficient mice were injected with the lab engineered human blood stem cells. It found the blood stem cells became functional bone marrow at similar levels to that seen in umbilical cord blood cell transplants, a proven benchmark of success.
The research also found the lab grown stem cells could be frozen prior to being successfully transplanted into the mice. This mimicked the preservation process of donor blood stem cells before being transplanted into patients.
MCRI Professor Ed Stanley said the findings could lead to new treatment options for a range of blood disorders.
“Red blood cells are vital for oxygen transport and white blood cells are our immune defence, while platelets cause clotting to stop us bleeding,” he said. Understanding how these cells develop and function is like decoding a complex puzzle.
“By perfecting stem cell methods that mimic the development of the normal blood stem cells found in our bodies we can understand and develop personalized treatments for a range of blood diseases, including leukemias and bone marrow failure.”
MCRI Professor Andrew Elefanty said while a blood stem cell transplant was often a key part of lifesaving treatment for childhood blood disorders, not all children found an ideally matched donor.
“Mismatched donor immune cells from the transplant can attack the recipient’s own tissues, leading to severe illness or death,” he said.
“Developing personalized, patient-specific blood stem cells will prevent these complications, address donor shortages and, alongside genome editing, help correct underlying causes of blood diseases.”
Professor Elefanty said the next stage, likely in about five years with government funding, would be conducting a phase one clinical trial to test the safety of using these lab-grown blood cells in humans.
Riya was diagnosed at the age of 11 with aplastic anemia, a rare and serious blood disorder where the body stops producing enough new blood cells.
Riya’s family, including parents Sonali and Gaurav Mahajan, were in India at the time when she started to feel fatigued, rapidly lost weight and developed bruises on her thighs.
“We took Riya for a simple blood test, her very first one. But as soon as the results came in, we were told to rush her to the emergency department due to her being so low on platelets and red blood cells,” Sonali said.
“Riya was originally diagnosed with leukemia because the symptoms are very similar to aplastic anemia. When we got the eventual diagnosis, it was a complete shock and a condition we had never heard of before.
“The doctors told us she had bone marrow failure and she started needing regular platelet and blood transfusions to get her blood cell count up.”
Sonali said the family had already planned to return to Australia for Riya’s high school education, but the diagnosis fast tracked the return.
“Once they were able to stabilize her, we were given a two-day window to fly her to Australia to be hospitalized,” she said.
“As soon as we got off the plane we went straight to The Royal Children’s Hospital. Within days Riya started therapy, but she never really responded to the medications.
“Eventually a bone marrow transplant was recommended due to the amount of transfusions she was needing to have and the concerns around possible long-term complications.”
Sonali said over six months they struggled to find a perfectly matched donor and were losing hope. Despite being a half match, Sonali, following specialist advice, became her daughter’s donor.
Following the bone marrow transplant in June last year, Riya remained in hospital for three months where she had minor complications.
Without a perfect donor match, Riya’s platelet count took more time to return to normal, she required longer immunosuppressive therapy and was more susceptible to infections. Riya only recently started to be re-vaccinated.
“She had a weakened immune system for a long time after the transplant but thankfully once she was discharged from the hospital she hasn’t needed another transplant,” Sonali said.
Riya, 14, said after a painful few years she was now feeling well, took hydrotherapy classes and was glad to be back at school with her friends.
Sonali said the new MCRI-led research on blood stem cells was a remarkable achievement.
“This research will come as a blessing to so many families,” she said. The fact that one day there could be targeted treatments for children with leukaemia and bone marrow failure disorders is life changing.”
Prof Elefanty, Prof Stanley and Associate Professor Ng are also Principal Investigators at the Melbourne node of the Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), a global consortium, which aims to pave the way for future stem cell-based treatments.
Researchers from the University of Melbourne, Peter MacCallum Cancer Centre, University of California Los Angeles, University College London and the University of Birmingham also contributed to the findings.
Ng, E. S., et al. (2024). Long-term engrafting multilineage hematopoietic cells differentiated from human induced pluripotent stem cells. Nature Biotechnology. doi.org/10.1038/s41587-024-02360-7.
News
Cancer Mystery Solved: Scientists Discover How Melanoma Becomes “Immortal”
Scientists have uncovered a previously overlooked mechanism that may help melanoma cells become effectively “immortal.” Cancer cells face a major problem before they can become deadly: They have to figure out how to stop [...]
How Visual Neurons Organize Thousands of Synaptic Inputs
Summary: A new study uncovered the organizational rules that determine how neurons in the primary visual cortex process information. By imaging both the cell bodies (soma) and the individual synapses (on dendritic spines) of [...]
Scientists Just Found a Surprising Way To Destroy “Forever Chemicals”
Scientists have uncovered a new mechanism that may help break down highly persistent PFAS pollutants. PFAS have earned the nickname “forever chemicals” for a reason. These industrial compounds are so chemically durable that they [...]
Scientists Discover Cheap Material That Kills Deadly Superbugs
A new sulfur-rich antimicrobial polymer shows strong effectiveness against fungal and bacterial pathogens and may offer an affordable solution to antimicrobial resistance. Antimicrobial resistance is creating growing challenges for both healthcare and food production, [...]
What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring
Like periodical cicadas, the insects for which it is nicknamed, SARS-CoV-2 Omicron subvariant BA.3.2 is only just beginning to emerge after lying low for an extended period since it first appeared. Although it was [...]
Scientists Say This Simple Supplement May Actually Reverse Heart Disease
Scientists in Japan say a common supplement may actually help “unclog” certain diseased heart arteries from the inside out. A simple food supplement sold in Japan may have helped reverse a dangerous form of [...]
New breakthrough against radiation: Korean Scientists create revolutionary shield with nanotechnology
Korean Scientists develop new nanotechnology material capable of reducing radiation impacts in space missions, hospitals, and power plants. The search for more efficient protection technologies in extreme environments has just gained an important advance. Korean [...]
Scientists Just Discovered the Hidden Trick That Keeps Your Cells Alive
A strange bead-like motion inside cells may be the secret to keeping their DNA—and health—in balance. Mitochondria are often described as the power plants of the cell because they produce the energy cells need [...]
Scientists Discover Stem Cells That Could Regrow Teeth and Bone
Scientists just uncovered the cellular “blueprint” that could one day let us regrow real teeth. Researchers at Science Tokyo have uncovered two distinct stem cell lineages that play a central role in forming tooth [...]
Scientists Uncover Fatal Weakness in “Zombie Cells” Linked to Cancer
A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own survival strategy against them. A new class of drugs takes advantage of a recently [...]
Bowel and Ovarian Cancers Are Dramatically Rising in Young Adults, Scientists Aren’t Sure Why
Cancer incidence is increasing, especially among younger adults, and current risk factors don’t fully account for the trend. Scientists suggest other underlying causes may be contributing. Cancer patterns in England are shifting in a [...]
New Immune Pathway Could Supercharge mRNA Cancer Vaccines
A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments. The arrival of mRNA vaccines against SARS-CoV-2 in 2020 marked a turning point in the COVID-19 pandemic. Today, [...]
Scientists Discover “Molecular Switch” That Fuels Alzheimer’s Brain Inflammation
A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer’s progression. The brain has its own built-in immune system that identifies threats and responds to them. In Alzheimer’s disease, growing evidence [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Forgotten Medicinal Plant Shows Promise in Fighting Dangerous Superbugs
A traditional medicinal plant, tormentil, shows promise against antibiotic-resistant bacteria in laboratory tests. Its compounds work by limiting bacterial growth and boosting antibiotic performance. Before the development of modern antibiotics, plant-based remedies were commonly [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
